Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)

NCT: NCT06153667 · RECRUITING

NCT IDNCT06153667
StatusRECRUITING
Start Date2024-08-22
SponsorMerit Medical Systems, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, multicenter, observational, post-market clinical follow-up study in subjects treated with Bearing nsPVA Embolization Particles for uterine fibroid embolization. Data collection will include safety and performance outcome relating to the use of Bearing nsPVA, through 6 months.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑